Bath & Body Works (NYSE:BBWI) Rating Increased to Hold at BMO Capital Markets

Key Points

• BMO Capital Markets upgraded Bath & Body Works to “Hold,” while the broader analyst consensus remains “Hold,” with 14 Hold, four Buy and one Sell rating and an average price target of $22.13.
• Shares opened at $17.45, near the lower end of their 52-week range of $14.27–$28.26. Other analysts have recently lowered price targets, including UBS to $17, Barclays to $22 and Robert W. Baird to $23.
• The company beat quarterly earnings expectations, reporting $0.62 EPS versus $0.24 expected and $1.51 billion in revenue, although revenue declined 2.3% year over year. Institutional investors own approximately 95.14% of the stock.

Bath & Body Works (NYSE:BBWI - Get Free Report) was upgraded by stock analysts at BMO Capital Markets to a "hold" rating in a research report issued on Tuesday, Zacks reports.

A number of other research firms have also recently commented on BBWI. UBS Group dropped their target price on Bath & Body Works from $19.00 to $17.00 and set a "neutral" rating on the stock in a research report on Thursday, August 27th. Barclays reduced their price target on Bath & Body Works from $23.00 to $22.00 and set an "equal weight" rating for the company in a report on Thursday, August 27th. Weiss Ratings upgraded Bath & Body Works from a "sell (d+)" rating to a "hold (c-)" rating in a research report on Thursday, July 9th. Piper Sandler began coverage on Bath & Body Works in a report on Friday, May 15th. They issued a "neutral" rating and a $20.00 price objective on the stock. Finally, Robert W. Baird cut their price objective on Bath & Body Works from $25.00 to $23.00 and set a "neutral" rating for the company in a research report on Thursday, August 27th. Four equities research analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $22.13.

Bath & Body Works Price Performance

NYSE:BBWI opened at $17.45 on Tuesday. The company has a 50 day moving average price of $19.71 and a 200-day moving average price of $19.63. Bath & Body Works has a 1-year low of $14.27 and a 1-year high of $28.26. The firm has a market cap of $3.52 billion, a price-to-earnings ratio of 4.54, a price-to-earnings-growth ratio of 1.82 and a beta of 1.38.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its quarterly earnings results on Wednesday, August 26th. The company reported $0.62 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.24 by $0.38. Bath & Body Works had a net margin of 10.83% and a negative return on equity of 53.48%. The firm had revenue of $1.51 billion for the quarter, compared to the consensus estimate of $1.50 billion. During the same period in the prior year, the firm posted $0.30 earnings per share. The firm's quarterly revenue was down 2.3% compared to the same quarter last year. Bath & Body Works has set its Q3 2026 guidance at 0.070-0.120 EPS and its FY 2026 guidance at 2.600-2.800 EPS. On average, sell-side analysts anticipate that Bath & Body Works will post 2.73 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Bath & Body Works

Several institutional investors have recently bought and sold shares of the company. Parallel Advisors LLC increased its position in shares of Bath & Body Works by 42.6% in the fourth quarter. Parallel Advisors LLC now owns 1,897 shares of the company's stock worth $38,000 after acquiring an additional 567 shares in the last quarter. State of Michigan Retirement System lifted its holdings in shares of Bath & Body Works by 1.2% during the 1st quarter. State of Michigan Retirement System now owns 49,300 shares of the company's stock valued at $920,000 after acquiring an additional 600 shares in the last quarter. Meeder Asset Management Inc. lifted its holdings in shares of Bath & Body Works by 28.5% during the 4th quarter. Meeder Asset Management Inc. now owns 2,874 shares of the company's stock valued at $58,000 after acquiring an additional 637 shares in the last quarter. State of Wyoming boosted its position in Bath & Body Works by 6.2% during the 2nd quarter. State of Wyoming now owns 11,294 shares of the company's stock worth $338,000 after purchasing an additional 661 shares during the period. Finally, Vident Advisory LLC boosted its position in Bath & Body Works by 2.8% during the 2nd quarter. Vident Advisory LLC now owns 25,229 shares of the company's stock worth $756,000 after purchasing an additional 692 shares during the period. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.